Winton Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,990
Closed -$50K 1830
2019
Q3
$50K Buy
+11,990
New +$50K ﹤0.01% 1499